dextrothyroxine has been researched along with azelaic acid in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 12 (92.31) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Fallen, RS; Gooderham, M | 1 |
Appell, M; Draelos, Z; Fleischer, A; Fowler, J; Jackson, JM; Jacovella, J; Kircik, L; Liu, H; Lynde, C; Stein Gold, L; Steinhoff, M; Sugarman, J; Tan, J | 1 |
Gallo, RL; Hata, TR; Two, AM; Wu, W | 1 |
Carter, B; Charland, L; Fedorowicz, Z; van der Linden, MM; van Zuuren, EJ | 1 |
Draelos, ZD; Gold, LM | 1 |
Asai, Y; Baibergenova, A; Barankin, B; Cochrane, CL; Humphrey, S; Lynde, CW; Marcoux, D; Poulin, Y; Rivers, JK; Sapijaszko, M; Sibbald, RG; Tan, J; Toole, J; Ulmer, M; Zip, C | 1 |
Helfrich, YR; Maier, LM | 1 |
Fowler, JF | 1 |
Alinia, H; Feldman, SR; Fleischer, A; McGregor, SP; Snyder, A; Tuchayi, SM | 1 |
Fritsch, P; Kolber, MR; Korownyk, C | 1 |
Cline, A; Gomolin, T; Pereira, F | 1 |
8 review(s) available for dextrothyroxine and azelaic acid
Article | Year |
---|---|
Rosacea: part II. Topical and systemic therapies in the treatment of rosacea.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Calcineurin Inhibitors; Dicarboxylic Acids; Humans; Ivermectin; Mast Cells; Patient Education as Topic; Retinoids; Rosacea; Serine Proteinase Inhibitors; Tetracyclines | 2015 |
Interventions for rosacea.
Topics: Anti-Infective Agents; Brimonidine Tartrate; Cyclosporine; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Ivermectin; Male; Metronidazole; Middle Aged; Ophthalmic Solutions; Quinoxalines; Randomized Controlled Trials as Topic; Rosacea; Tetracycline | 2015 |
New and Emerging Treatments for Rosacea.
Topics: Administration, Topical; Brimonidine Tartrate; Clinical Trials, Phase III as Topic; Dermatologic Agents; Dicarboxylic Acids; Drug Approval; Female; Follow-Up Studies; Forecasting; Humans; Ivermectin; Male; Oxymetazoline; Patient Satisfaction; Rosacea; Severity of Illness Index; Treatment Outcome; United States; United States Food and Drug Administration | 2015 |
Canadian Clinical Practice Guidelines for Rosacea.
Topics: Anti-Infective Agents; Consensus; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Eye Diseases; Humans; Intense Pulsed Light Therapy; Isotretinoin; Ivermectin; Laser Therapy; Metronidazole; Outliers, DRG; Practice Guidelines as Topic; Rosacea; Tetracycline | 2016 |
Topical and oral therapeutic approach to rosacea.
Topics: Administration, Cutaneous; Administration, Oral; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Evidence-Based Medicine; Humans; Ivermectin; Metronidazole; Rosacea; Treatment Outcome | 2016 |
A Review of the Current Modalities for the Treatment of Papulopustular Rosacea.
Topics: Administration, Cutaneous; Anti-Infective Agents; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Humans; Ivermectin; Metronidazole; Rosacea | 2018 |
Rosacea First-choice treatments.
Topics: Administration, Cutaneous; Administration, Oral; Adrenergic alpha-2 Receptor Agonists; Anti-Bacterial Agents; Antiparasitic Agents; Azithromycin; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Humans; Ivermectin; Metronidazole; Rosacea | 2017 |
Treatment of rosacea during pregnancy.
Topics: Adult; Algorithms; Animals; Anti-Bacterial Agents; Azithromycin; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Isotretinoin; Ivermectin; Metronidazole; Mice; Minocycline; Phototherapy; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Rosacea; Tetracyclines; Treatment Outcome | 2021 |
1 trial(s) available for dextrothyroxine and azelaic acid
Article | Year |
---|---|
Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Dermatologic Agents; Dicarboxylic Acids; Female; Gels; Humans; Ivermectin; Male; Middle Aged; Rosacea; Single-Blind Method; Skin Cream; Time Factors; Young Adult | 2014 |
4 other study(ies) available for dextrothyroxine and azelaic acid
Article | Year |
---|---|
Rosacea: update on management and emerging therapies.
Topics: Administration, Cutaneous; Adrenergic Agents; Anti-Infective Agents; Antiparasitic Agents; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Ivermectin; Male; Metronidazole; Oxymetazoline; Quality of Life; Quinoxalines; Randomized Controlled Trials as Topic; Rosacea; Sulfacetamide; Treatment Outcome | 2012 |
Ivermectin cream for rosacea.
Topics: Adult; Clinical Trials as Topic; Dicarboxylic Acids; Drug Interactions; Humans; Ivermectin; Metronidazole; Ointments; Rosacea | 2015 |
Facial Dermatitis and Rosacea.
Topics: Adrenal Cortex Hormones; Adrenergic alpha-2 Receptor Agonists; Antimicrobial Cationic Peptides; Antiparasitic Agents; Brimonidine Tartrate; Cathelicidins; Dermatitis; Dermatologic Agents; Dicarboxylic Acids; Facial Dermatoses; Humans; Ivermectin; Rosacea | 2016 |
Topical treatments for rosacea.
Topics: Administration, Topical; Dicarboxylic Acids; Drug Costs; Humans; Ivermectin; Metronidazole; Patient Reported Outcome Measures; Rosacea | 2019 |